Sat, Dec 27, 2014, 5:43 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Athersys, Inc. Message Board

  • biohitechinvestor biohitechinvestor Feb 15, 2013 4:02 PM Flag

    Very strong support here...

    even after a big move from $1 to $1.70. With some good news this things doubles from here easily and more. Hope Pfizer knows what it's doing...Have a nice long weekend.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Pfizer? do you have facts?

      • 2 Replies to dsscott2001
      • The company has been garnering large amounts of attention surrounding the prolific nature of its adult stem cell product, MultiStem, and its partnership with Pfizer, Inc. (NYSE:PFE). Pfizer has commenced a Phase II clinical trial in Inflammatory Bowel Disease with topline data expected later this year. As often is the case, stocks begin an ascent as investors start to anticipate clinical data. Being in a partnership with the world’s biggest drug maker (whom happens to have a stack of cash and a thin pipeline), has the spotlight on Athersys to produce promising mid-stage results.
        Further, the investment community seems to be becoming more cognizant about Athersys’ partnership with RTI Biologics, Inc. (Nasdaq:RTIX) that has netted Athersys more than $5 million in licensing and milestone payments to date. RTI has licensed the MultiStem technology to isolate and preserve cells from organ and tissue donors for research on its Bone Allograft product.

        Sentiment: Strong Buy

      • Read the headlines. They do have a collaboration deal with Pfizer...so we'll see where this leads.

        Sentiment: Strong Buy

 
ATHX
1.300.00(0.00%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST
Fluor Corporation
NYSEFri, Dec 26, 2014 4:03 PM EST